| Recruiting | First in Human Study of SIM0610 in Solid Tumors Advanced Solid Tumours, Non-Small Cell Lung Cancer, Colorectal Cancer | Phase 1 | 2026-01-19 |
| Not Yet Recruiting | A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharma Health, Subjective | Phase 1 | 2026-01-13 |
| Recruiting | An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chi Healthy Adult Participants | Phase 1 | 2026-01-05 |
| Recruiting | A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer Refractory Metastatic Colorectal Cancer | Phase 3 | 2025-11-12 |
| Recruiting | A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Advanced Solid Cancer | Phase 1 | 2025-11-07 |
| Not Yet Recruiting | A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermati Atopic Dermatitis (AD) | Phase 2 | 2025-10-27 |
| Recruiting | A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors Locally Advanced Solid Tumors | Phase 1 | 2025-05-20 |
| Recruiting | A Phase I Study of SIM0388 in Participants With Malignant Ascites. Malignant Ascites | Phase 1 | 2025-04-24 |
| Recruiting | Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-12-06 |
| Recruiting | A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Adv Locally Advanced or Metastatic Breast Cancer | Phase 3 | 2024-11-14 |
| Active Not Recruiting | Mass Balance Clinical Trial of SIM0270 Healthy Participants | Phase 1 | 2024-10-17 |
| Completed | Evaluate the Effects of Food on the Pharmacokinetics of SIM0270 Healthy Participants | Phase 1 | 2024-07-23 |
| Recruiting | Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma Relapsed or Refractory Multiple Myeloma | Phase 1 | 2024-05-24 |
| Terminated | Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-03-19 |
| Recruiting | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone o Non-Muscle-Invasive Bladder Cancer (NMIBC) | Phase 1 | 2024-01-23 |
| Completed | Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Su Healthy Volunteer | Phase 1 | 2023-09-04 |
| Completed | A Study of Daridorexant in Chinese Patients With Insomnia Disorder Insomnia Disorder | Phase 3 | 2023-08-28 |
| Completed | To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subj Healthy Volunteers | Phase 1 | 2023-08-23 |
| Unknown | Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly Subjects Elder | Phase 1 | 2023-04-07 |
| Active Not Recruiting | Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2023-03-29 |
| Terminated | A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM023 Locally Advanced Unresectable or Metastatic Solid Tumor | Phase 1 | 2023-03-08 |
| Unknown | Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir Renal Impairment, Hepatic Impairment | Phase 1 | 2023-03-01 |
| Completed | Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy Partic Healthy Volunteers | Phase 1 | 2022-12-29 |
| Unknown | A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) | Phase 1 | 2022-09-30 |
| Completed | A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Sympt COVID-19 | Phase 2 / Phase 3 | 2022-08-19 |
| Completed | Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participa Healthy Male Volunteers | Phase 1 | 2022-07-21 |
| Unknown | To Evaluate SSD8432/Ritonavir in Adults With COVID-19 COVID-19 | Phase 2 / Phase 3 | 2022-05-26 |
| Unknown | Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Clinical Study COVID-19 | Phase 2 | 2022-05-20 |
| Recruiting | A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tum Solid Tumor, Non Hodgkin Lymphoma | Phase 1 | 2022-05-18 |
| Active Not Recruiting | Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Breast Cancer | Phase 1 | 2022-05-18 |
| Completed | To Evaluate SSD8432/ Ritonavir in Adults With COVID-19 COVID-19 Patients | Phase 1 / Phase 2 | 2022-05-12 |
| Unknown | A Phase I Clinical Study of SSD8432 in Healthy Adult Subjects Healthy Participants | Phase 1 | 2022-04-07 |
| Unknown | A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 2 | 2022-02-01 |
| Terminated | A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 2 | 2021-12-22 |
| Completed | The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese Volunteers Acute Ischemic Stroke, Cerebral Edema | Phase 1 | 2021-12-06 |
| Completed | Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemot Extensive-stage Small-cell Lung Cancer | Phase 4 | 2021-08-11 |
| Unknown | PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemother Advanced or Metastatic NSCLC | Phase 1 | 2021-07-30 |
| Active Not Recruiting | A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection Malignant Pleural Effusion | Phase 3 | 2021-07-28 |
| Completed | A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Can Ovarian Cancer | Phase 3 | 2021-06-11 |
| Completed | Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patien Extensive-stage Small-cell Lung Cancer | Phase 3 | 2021-05-25 |
| Unknown | A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Primary Sjögren Syndrome | Phase 2 | 2021-03-22 |
| Unknown | An Open Label, Multi-center, Phase I Clinical Study to Evaluate the Safety, Effectiveness and Pharmacokinetic Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion | Phase 1 | 2020-12-21 |
| Unknown | A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tum NSCLC, Solid Tumor | Phase 1 | 2020-04-02 |
| Unknown | A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant R Ovarian Cancer | Phase 1 | 2018-04-24 |
| Completed | A Pilot Bioequivalence Study of Pomalidomide Bioequivalence | Phase 1 | 2018-01-19 |
| Unknown | Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously Rheumatoid Arthritis (RA) | Phase 1 | 2016-10-01 |
| Unknown | Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relaps Multiple Myeloma | Phase 3 | 2016-09-01 |
| Unknown | A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to M Rheumatoid Arthritis (RA) | Phase 3 | 2016-08-01 |
| Unknown | Study of Metatinib Tromethamine Tablet Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Liver Cancer, Advanced or Metastatic CRC | Phase 1 | 2015-10-01 |
| Unknown | Study of Endostar Subcutaneous Injection in NSCLC NSCLC | Phase 1 | 2015-08-01 |
| Unknown | A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Pa Metastatic Colorectal Cancer | Phase 1 | 2015-08-01 |
| Completed | Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke Acute Ischemic Stroke | Phase 3 | 2015-05-01 |
| Unknown | The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combinat Lung Cancer | Phase 3 | 2014-11-01 |
| Unknown | Fluorouracil Implants Used for Intraperitoneal Chemotherapy During Operation for Treatment of Phase III Gastri DSF | Phase 2 | 2014-04-01 |
| Completed | Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma Squamous Cell Carcinoma | Phase 4 | 2013-12-01 |
| Unknown | Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Art Rheumatoid Arthritis | Phase 4 | 2013-09-01 |
| Completed | Compound Edaravone Injection for Acute Ischemic Stroke Acute Ischemic Stroke | Phase 2 | 2013-08-01 |
| Completed | Phase I Clinical Study of Metatinib Tromethamine Tablet Advanced or Metastatic Solid Tumors | Phase 1 | 2013-05-01 |
| Unknown | A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patien Advanced Solid Tumors, Metastatic Solid Tumors | Phase 1 | 2013-04-01 |
| Unknown | Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients Non-small Cell Lung Cancer | Phase 1 | 2012-12-01 |
| Unknown | Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI Rheumatoid Arthritis | Phase 4 | 2012-07-01 |
| Unknown | Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumat Rheumatoid Arthritis | Phase 4 | 2012-05-01 |
| Completed | A Study of Iguratimod in Patients With Active Rheumatoid Arthritis Rheumatoid Arthritis | Phase 4 | 2012-05-01 |
| Completed | Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China Influenza A Virus Infection, Influenza B Virus Infection | Phase 3 | 2011-10-01 |
| Completed | The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly E Cancer | Phase 2 | 2011-10-01 |
| Completed | A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non S Non-Small Cell Lung Cancer | Phase 1 | 2011-09-01 |
| Completed | Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Simotinib Hydrochloride in Healthy Sub Healthy | Phase 1 | 2011-09-01 |
| Unknown | Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases Brain Metastases | Phase 2 | 2011-06-01 |
| Unknown | Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients Esophageal Cancer | Phase 2 | 2011-05-01 |
| Completed | Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites Malignant Pleural Effusion, Malignant Ascites | Phase 2 | 2011-03-01 |
| Completed | Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia | Phase 2 | 2010-03-01 |
| Completed | Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypert Essential Hypertension | Phase 4 | 2009-12-01 |